Company
Building the infrastructure for repeatable human capability.
CloneCorp was founded around a simple enterprise observation: exceptional people create bottlenecks when organizations cannot reproduce their capability.
2018
Founded
CloneCorp establishes its first private replication research program.
2022
Enterprise Network
Multi-site deployment operations begin under controlled enterprise agreements.
2026
Global Scale
Replication infrastructure expands across fourteen operational facilities.
Leadership
Operational, scientific, legal.
Elena Voss
Chief Executive Officer
Dr. Adrian Cole
Chief Scientific Officer
Mara Chen
General Counsel & Chief Governance Officer